Markets:

Overview

News

Currencies

International

Treasuries

Autolus Therapeutics plc - American Depositary Shares (NQ:AUTL)

1.465 -0.045 (-2.98%)

Streaming Delayed Price Updated: 2:22 PM EDT, Jul 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Autolus Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 08, 2021

Gainers PetVivo Holdings (NASDAQ:PETV) s...

Via Benzinga

DSAC Stock Pops on FiscalNote SPAC Merger News. 14 Things to Know. ↗

November 08, 2021

Duddell Street Acquisition (DSAC) stock is on the move Monday following news of a special purpose acquisition company merger with FiscalNote.

Via InvestorPlace

Chinese Stocks Alert: The Turnaround Story Driving TAL, EDU, METX, GOTU Stocks Higher ↗

November 08, 2021

Chinese education stocks are moving higher on Monday as reports claim China will allow companies to resume their after-school tutoring.

Via InvestorPlace

AUTL Stock: Why Little-Known Autolus Therapeutics Is Rocketing Higher Today ↗

November 08, 2021

Autolus Therapeutics (AUTL) stock is surging higher in trading Monday following news of a major investment in the company.

Via InvestorPlace

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Mid-Morning Market Update: Markets Rise; Coty Posts Upbeat Earnings ↗

November 08, 2021

Following the market opening Monday, the Dow traded up 0.40% to 36,472.70 while the NASDAQ rose 0.20% to 16,003.39. The S&P also rose, gaining 0.15% to 4,704.42. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 08, 2021

Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The company's market cap stands at $490.7 million. As per...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 08, 2021

Welcome back, trader! We're starting off the week strong with a dive into the biggest pre-market stock movers for Monday.

Via InvestorPlace

26 Stocks Moving in Monday's Pre-Market Session ↗

November 08, 2021

Gainers Autolus Therapeutics plc (NASDAQ: AUTL) rose 32.6% to $7.37 in pre-market trading. Syncona said Blackstone Life Science will invest $250 million in Autolus. Mainz Biomed...

Via Benzinga

Autolus Stock Rallies On $250M Investment From Blackstone ↗

November 08, 2021

Blackstone Inc (NYSE: BX) will invest $250 million in Autolus Therapeutics plc (NASDAQ: AUTL) to fund the final stages of developing a new therapy to...

Via Benzinga

Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well ↗

October 08, 2021

The FDA has sent shockwaves through the off-the-shelf CAR-T space after it slapped a clinical hold on all of the Allogene Therapeutics Inc (NASDAQ: ALLO)...

Via Benzinga

Autolus' Blood Cancer CAR T-Cell Therapy Receives Promising Innovative Medicine In UK ↗

August 09, 2021

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted Promising Innovative Medicine (PIM) designation to Autolus Therapeutics plc's...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 02, 2021

Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading volume for Xenetic Biosciences's stock is 10.1...

Via Benzinga

Here's Why Autolus Therapeutics Is Surging Today ↗

August 02, 2021

Potential licensing agreements with Moderna are giving investors reasons to cheer.

Via The Motley Fool

Autolus Stock Jumps On Cancer mRNA Therapeutics Agreement With Moderna ↗

August 02, 2021

Autolus Therapeutics plc (NASDAQ: AUTL) has granted Moderna Inc (NASDAQ: MRNA) an exclusive license to develop and commercialize mRNA therapeutics...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 02, 2021

Gainers Exicure (NASDAQ:XCUR) stock moved upwards by 35.55% to $1.83 during Monday's pre-market session. The company's market cap stands at $161.0 million....

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 25, 2021

Gainers Reshape Lifesciences (NASDAQ:RSLS...

Via Benzinga

Autolus Therapeutics' CAR T Cell Achieves 100% Complete Remission In Indolent B Cell Non-Hodgkin Cohort ↗

June 11, 2021

Autolus Therapeutics plc (NASDAQ: AUTL) has announced new data from AUTO1 (obecabtagene autoleucel, obe-cel) in relapsed / refractory (r/r) indolent B cell...

Via Benzinga

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗

June 07, 2021

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 21, 2021

Gainers Sio Gene Therapies (NASDAQ:SIOX) ...

Via Benzinga

62 Biggest Movers From Yesterday ↗

May 13, 2021

Gainers Curis, Inc. (NASDAQ: CRIS) shares surged 65.5% to settle at $16.27 on Wednesday in reaction to updated data from its ongoing open-label, single-arm, Phase 1/2 study of CA...

Via Benzinga

Why Autolus Therapeutics Stock Skyrocketed Today ↗

May 12, 2021

The company announced encouraging clinical trial data for its experimental cell therapy, AUTO1.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 12, 2021

Gainers Curis (NASDAQ:CRIS) shares moved upwards by 57.23% to $15.46 during Wednesday's regular session. Trading volume for Curis's stock is 28.8 million as of 12:...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

May 12, 2021

Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 76% to $5.84 after the company reported better-than-expected Q1 results. Lucira Health, Inc. (NASDAQ: LHDX) gained...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.